Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Total Liabilities ₹405 Cr₹378 Cr₹308 Cr₹184 Cr₹181 Cr

What is the latest Total Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹405 Cr based on Mar2024 Consolidated results.
Year Total Liabilities
Mar2024₹405 Cr
Mar2023₹378 Cr
Mar2022₹308 Cr
Mar2017₹184 Cr
Mar2016₹181 Cr

How is Total Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Liabilities % Change
Mar2024 ₹405 Cr
7.10
Mar2023 ₹378 Cr
22.58
Mar2022 ₹308 Cr
67.59
Mar2017 ₹184 Cr
1.81
Mar2016 ₹181 Cr -

Compare Total Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹2,014.4 Cr 1% 42.4% 81.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,519.0 Cr 1.6% -2.9% 17.2% Stock Analytics
DIVIS LABORATORIES ₹175,903.0 Cr 1.5% 10.4% 51.9% Stock Analytics
CIPLA ₹121,669.0 Cr 2.3% 1.9% 2.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,097.0 Cr 5.7% 14.1% 15.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,605.0 Cr 1.4% 1.3% 17% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

1%

42.4%

81.3%

SENSEX

1.3%

2.6%

7.8%


You may also like the below Video Courses